Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NKAIN1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
mRNA | IL2RA | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
mRNA | LCORL | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
mRNA | PKD1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
mRNA | WRN | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
mRNA | DOLK | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
mRNA | NUBP2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
mRNA | ZNF92 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
mRNA | RPS7 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
mRNA | TMED3 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |